Aggression in autism spectrum disorder: presentation and treatment options

被引:139
|
作者
Fitzpatrick, Sarah E. [1 ]
Srivorakiat, Laura [1 ]
Wink, Logan K. [1 ]
Pedapati, Ernest V. [1 ]
Erickson, Craig A. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA
来源
关键词
autism; autism spectrum disorder; aggression; treatment; antipsychotics; applied behavior analysis; PERVASIVE DEVELOPMENTAL DISORDERS; PLACEBO-CONTROLLED TRIAL; RAPID CLOZAPINE TITRATION; CONTROLLED CLINICAL-TRIAL; OF-THE-LITERATURE; DOUBLE-BLIND; OPEN-LABEL; INTELLECTUAL DISABILITIES; FUNCTIONAL-ANALYSIS; BEHAVIOR PROBLEMS;
D O I
10.2147/NDT.S84585
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent difficulties in social communication and social interaction, coupled with restricted, repetitive patterns of behavior or interest. Research indicates that aggression rates may be higher in individuals with ASD compared to those with other developmental disabilities. Aggression is associated with negative outcomes for children with ASD and their caregivers, including decreased quality of life, increased stress levels, and reduced availability of educational and social support. Therapeutic strategies including functional behavioral assessment, reinforcement strategies, and functional communication training may have a significant impact in reducing the frequency and intensity of aggressive behavior in individuals with ASD. Pharmacologic treatments, particularly the use of second-generation antipsychotics, may also be of some benefit in reducing aggression in individuals with ASD. With the ever-increasing rate of ASD diagnosis, development of effective therapeutic and pharmacologic methods for preventing and treating aggression are essential to improving outcomes in this disorder.
引用
收藏
页码:1525 / 1538
页数:14
相关论文
共 50 条
  • [31] The neurobiological presentation of anxiety in autism spectrum disorder: A systematic review
    McVey, Alana J.
    AUTISM RESEARCH, 2019, 12 (03) : 346 - 369
  • [32] Difficult-to-Treat Aggression in a Child with Autism Spectrum Disorder: Did We Miss Something? Bipolar Disorder As a Comorbid Psychiatric Condition in Autism Spectrum Disorder
    Zaydlin, Michelle
    Cara, Valentina Metsavaht
    Bez, Yasin
    Coffey, Barbara J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (09) : 500 - 504
  • [33] Cannabinoid treatment for the symptoms of autism spectrum disorder
    Aran, Adi
    Rand, Dalit Cayam
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (01) : 65 - 79
  • [34] A Ketogenic Diet and the Treatment of Autism Spectrum Disorder
    Li, Qinrui
    Liang, Jingjing
    Fu, Na
    Han, Ying
    Qin, Jiong
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [35] Autism Spectrum Disorder: Pathophysiology and Treatment Implications
    Anderson, George
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (41) : 4319 - 4320
  • [36] An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
    Aishworiya, Ramkumar
    Valica, Tatiana
    Hagerman, Randi
    Restrepo, Bibiana
    NEUROTHERAPEUTICS, 2022, 19 (01) : 248 - 262
  • [37] Oxytocin for the treatment of autism spectrum disorder in children
    Griffiths, Justin L.
    Mishaal, Ram A.
    Nabetani, Makoto
    Goldman, Ran D.
    CANADIAN FAMILY PHYSICIAN, 2022, 68 (02) : 106 - 108
  • [38] Use of dog in the treatment of Autism Spectrum Disorder
    Paredes-Ramos, Pedro
    Perez-Pouchoulen, Miguel
    Garcia-Banuelos, Paulina
    Martinez-Conde, Rosa
    Rioux, Marie
    Manzo, Jorge
    Coria-Avila, Genaro
    ENEUROBIOLOGIA, 2012, 3 (06):
  • [39] Sulforaphane treatment of autism spectrum disorder (ASD)
    Singh, Kanwaljit
    Connors, Susan L.
    Macklin, Eric A.
    Smith, Kirby D.
    Fahey, Jed W.
    Talalay, Paul
    Zimmerman, Andrew W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (43) : 15550 - 15555
  • [40] Pharmacology in the Treatment of Severe Autism Spectrum Disorder
    Le, Jennifer F.
    Lohr, W. David
    PEDIATRIC ANNALS, 2012, 41 (10): : E201 - E203